Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
BridgeBio Oncology Therapeutics, Inc. - Common Stock
(NQ:
BBOT
)
10.24
+0.26 (+2.61%)
Streaming Delayed Price
Updated: 9:43 AM EST, Feb 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
13,481
Open
9.930
Bid (Size)
10.09 (200)
Ask (Size)
10.37 (100)
Prev. Close
9.980
Today's Range
9.900 - 10.25
52wk Range
9.800 - 14.87
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BBOT to Participate in Upcoming Investor Healthcare Conferences
February 12, 2026
From
TheRas, Inc. (d/b/a BBOT)
Via
GlobeNewswire
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
February 11, 2026
From
TheRas, Inc. (d/b/a BBOT)
Via
GlobeNewswire
Performance
YTD
-16.7%
-16.7%
1 Month
-18.9%
-18.9%
3 Month
-16.7%
-16.7%
6 Month
-17.7%
-17.7%
1 Year
-17.7%
-17.7%
More News
Read More
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
January 13, 2026
From
TheRas, Inc. (d/b/a BBOT)
Via
GlobeNewswire
BBOT Announces New Clinical Data Advancing Its Portfolio of Three Innovative and Differentiated RAS and PI3Kα Pipeline Programs
January 07, 2026
From
TheRas, Inc. (d/b/a BBOT)
Via
GlobeNewswire
Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million?
↗
December 22, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
BBOT to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 16, 2025
From
TheRas, Inc. (d/b/a BBOT)
Via
GlobeNewswire
BBOT Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
December 11, 2025
From
TheRas, Inc. (d/b/a BBOT)
Via
GlobeNewswire
BBOT Announces Late-Breaking Preclinical Data on BBO-10203, a First-in-Class RAS:PI3Kα Breaker, at the San Antonio Breast Cancer Symposium (SABCS)
December 10, 2025
From
TheRas, Inc. (d/b/a BBOT)
Via
GlobeNewswire
BBOT to Participate in Upcoming December Investor Healthcare Conferences
November 18, 2025
From
TheRas, Inc. (d/b/a BBOT)
Via
GlobeNewswire
BBOT Reports Third Quarter 2025 Financial Results and Update on Corporate Progress
November 12, 2025
From
TheRas, Inc. (d/b/a BBOT)
Via
GlobeNewswire
BBOT to Participate in the Jefferies Global Healthcare Conference in London
November 03, 2025
From
TheRas, Inc. (d/b/a BBOT)
Via
GlobeNewswire
BBOT Announces Poster Presentations at the San Antonio Breast Cancer Symposium (SABCS)
October 30, 2025
From
TheRas, Inc. (d/b/a BBOT)
Via
GlobeNewswire
Preclinical Data Presented at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Support Potential of BBO-10203, a First-in-Class RAS:PI3Kα Breaker That Inhibits KRAS-Mutant Tumor Growth without Inducing
October 25, 2025
From
TheRas, Inc. (d/b/a BBOT)
Via
GlobeNewswire
BBOT Presents Preclinical Data Demonstrating Potential of BBO-11818 as a Potent panKRAS Inhibitor at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 23, 2025
From
TheRas, Inc. (d/b/a BBOT)
Via
GlobeNewswire
BBOT Announces Poster Presentations at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 13, 2025
From
TheRas, Inc. (d/b/a BBOT)
Via
GlobeNewswire
Frequently Asked Questions
Is BridgeBio Oncology Therapeutics, Inc. - Common Stock publicly traded?
Yes, BridgeBio Oncology Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does BridgeBio Oncology Therapeutics, Inc. - Common Stock trade on?
BridgeBio Oncology Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for BridgeBio Oncology Therapeutics, Inc. - Common Stock?
The ticker symbol for BridgeBio Oncology Therapeutics, Inc. - Common Stock is BBOT on the Nasdaq Stock Market
What is the current price of BridgeBio Oncology Therapeutics, Inc. - Common Stock?
The current price of BridgeBio Oncology Therapeutics, Inc. - Common Stock is 10.24
When was BridgeBio Oncology Therapeutics, Inc. - Common Stock last traded?
The last trade of BridgeBio Oncology Therapeutics, Inc. - Common Stock was at 02/23/26 09:43 AM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
